Development Level

Tbio 4 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

Disease

Obesity 6 | 616
diabetes mellitus 6 | 1,663
Cancer 5 | 2,346
Neuropathy 5 | 210
psoriasis 5 | 6,685
Alzheimer's disease 4 | 644
Autistic Disorder 4 | 320
Dementia 4 | 129
Hypertension 4 | 287
Schizophrenia 4 | 501
glioblastoma 4 | 5,572
pediatric high grade glioma 4 | 2,712
Anorexia nervosa 3 | 59
Asthma 3 | 349
Cerebrovascular disease 3 | 231
Epilepsy 3 | 346
Hypoglycemia 3 | 81
Infertility 3 | 163
Inflammation 3 | 109
Inflammatory bowel disease 3 | 142
Major Depressive Disorder 3 | 106
Mammary Neoplasms 3 | 410
Metabolic syndrome X 3 | 155
Nerve Degeneration 3 | 73
Pain agnosia 3 | 99
Parkinson's disease 3 | 364
Seizures 3 | 95
interstitial cystitis 3 | 2,299
lung cancer 3 | 4,466
lung carcinoma 3 | 2,844
malignant mesothelioma 3 | 3,162
oligodendroglioma 3 | 2,849
ovarian cancer 3 | 8,484
pilocytic astrocytoma 3 | 3,086
Acquired metabolic disease 2 | 267
Alcohol dependence 2 | 107
Allergic hypersensitivity disease 2 | 123
Amenorrhea 2 | 60
Amnestic disorder 2 | 37
Amyotrophic Lateral Sclerosis 2 | 431
Anxiety Disorders 2 | 37
Anxiety disorder 2 | 22
Arthritis 2 | 248
Atherosclerosis 2 | 275
Bipolar Disorder 2 | 266
Brain Ischemia 2 | 87
Brain disease 2 | 83
Breast cancer 2 | 3,094
Bulimia nervosa 2 | 15
Cardiomegaly 2 | 66
Chorioamnionitis 2 | 15
Cocaine-Related Disorders 2 | 88
Colitis 2 | 46
Colonic Neoplasms 2 | 126
Coronary artery disease 2 | 240
Dermatitis 2 | 107
Diabetes Mellitus, Experimental 2 | 106
Diarrhea 2 | 155
Drug-Induced Liver Injury 2 | 118
Endometriosis 2 | 535
Endometritis 2 | 21
Heart disease 2 | 279
Huntington's disease 2 | 72
Hyperactive behavior 2 | 31
Hyperalgesia 2 | 71
Hyperglycemia 2 | 120
Hypertensive disease 2 | 193
Hypotension 2 | 53
Intellectual disability 2 | 573
Irritable bowel syndrome 2 | 59
Kidney disease 2 | 396
Liver Cirrhosis, Experimental 2 | 108
Liver disease 2 | 219
Lung disease 2 | 132
Mammary Neoplasms, Experimental 2 | 150
Mastitis 2 | 48
Multiple Sclerosis 2 | 498
Myocardial Ischemia 2 | 169
Myopathy 2 | 128
Neurodegenerative disease 2 | 383
Osteoporosis 2 | 257
Prader-Willi syndrome 2 | 45
Pulmonary Fibrosis 2 | 66
Rhinitis 2 | 46
Skin disease 2 | 65
Spontaneous abortion 2 | 108
Stomach Neoplasms 2 | 282
Tonic-clonic epilepsy 2 | 47
Toxic encephalopathy 2 | 131
Urticaria 2 | 53
astrocytic glioma 2 | 2,241
chronic kidney disease 2 | 90
group 4 medulloblastoma 2 | 1,875
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
lung adenocarcinoma 2 | 2,713
osteosarcoma 2 | 7,933
pancreatic cancer 2 | 2,300
posterior fossa group A ependymoma 2 | 1,511
primitive neuroectodermal tumor 2 | 3,031
tuberculosis 2 | 1,557

Tissue

Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Nervous System 7 | 18,561
Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Male tissues 6 | 17,969
Respiratory system 6 | 17,484
Liver and Pancreas 5 | 18,136
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 7 | 11,971

Grant Application

2R01NS032507-05A2 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interleukin-1 beta IL1B Tclin Non-IDG -4.34333 22444.2 1345
Ciliary neurotrophic factor CNTF Tbio Non-IDG -2.93804 991.3 390
Oxytocin-neurophysin 1 OXT Tbio Non-IDG -4.16090 14677.4 133
Brain-derived neurotrophic factor BDNF Tbio Non-IDG -3.94336 9826.7 594
Filamin-A FLNA Tbio Non-IDG -3.30580 2117.1 432
Insulin-like growth factor I IGF1 Tchem Non-IDG -4.29982 21900.3 689
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86